Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Marc Rubin is Director at Curis. OQRO lists 7 transactions filed with the SEC under this name, the latest on Jul 9, 2026, each linked to the official Form 4.
Director
Disclosures on record
7
Companies involved
1
Marc Rubin bought shares on the open market in 2010, 2011, 2013 and 2017, and has not bought since 2017 across 2 companies. Sales in 2 of the 17 years since 2010.
Marc Rubin reported 5 open-market purchases and 6 sales since 2010; purchases in 4 different years, most recently 2017.
| Year | Bought | Sold |
|---|---|---|
| 2019 | — | $327K4×4 trades |
| 2018 | — | $432K2×2 trades |
| 2017 | $37K2×2 trades | — |
| 2013 | $26K1×1 trade | — |
| 2011 | $19K1×1 trade | — |
| 2010 | $50K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
CurisCRIS
7 disclosures · Mar 2026 – Jul 2026
Jul 7, 20266,800disclosed Jul 9
DetailsOfficial recordMar 20, 202627Kdisclosed Mar 23
DetailsOfficial recordMar 20, 202620disclosed Mar 23
DetailsOfficial recordMar 17, 202620disclosed Mar 18
DetailsOfficial recordMar 17, 202627Kdisclosed Mar 18
DetailsOfficial recordMar 17, 202627Kdisclosed Mar 18
DetailsOfficial recordMar 17, 202627Kdisclosed Mar 18
DetailsOfficial recordAs of the latest filing on , Marc Rubin reported holding 28,108 shares of Curis (CRIS), worth about $13K at the last close of $0 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Curis CRIS | 28,108 | 28K direct | $0 | $13K | Mar 20, 2026 |
Is this Marc Rubin’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Mar 20, 2026, Marc Rubin reported holding 28,108 shares of Curis (CRIS). At the last close of $0 on Nov 13, 2026, that is about $13K. This is the stake disclosed in filings, not a net worth.
Marc Rubin bought shares on the open market in 2010, 2011, 2013 and 2017, and has not bought since 2017 across 2 companies. Sales in 2 of the 17 years since 2010.
In SEC filings since 2010: the latest open-market purchase is from 2017; the latest open-market sale is from 2019.
2 companies: Galectin Therapeutics (GALT, 2011–2019), Curis (CRIS, 2010–2019).
Marc Rubin reported 3 open-market purchases and 5 sales here, 2011 to 2019.
Marc Rubin reported 2 open-market purchases and 1 sale here, 2010 to 2019.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.